2003Proc Natl Acad Sci U S A
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies.
L Hangartner, B M Senn, B Ledermann, U Kalinke, P Seiler, E Bucher, R M Zellweger, K Fink, B Odermatt, K Burki, R M Zinkernagel, H Hengartner
2006Discov Med
Vaccination against prion diseases
U Kalinke, P Bach, M Konig, C J Buchholz
2006Expert Opin Biol Ther
Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies
C J Buchholz, P Bach, D Nikles, U Kalinke
2005J Immunol
Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus
B Strobl, I Bubic, U Bruns, R Steinborn, R Lajko, T Kolbe, M Karaghiosoff, U Kalinke, S Jonjic, M Muller
2002J Exp Med
Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
S Scheu, J Alferink, T Potzel, W Barchet, U Kalinke, K Pfeffer
2006Blood
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia
E Kamphuis, T Junt, Z Waibler, R Forster, U Kalinke
2006J Immunother
Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective
T Hinz, C J Buchholz, T van der Stappen, K Cichutek, U Kalinke
2006J Immunol
CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion
P Aichele, H Unsoeld, M Koschella, O Schweier, U Kalinke, S Vucikuja
2006J Gen Virol
Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara
C Staib, Y Suezer, S Kisling, U Kalinke, G Sutter
2002J Exp Med
Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo.
W Barchet, M Cella, B Odermatt, C Asselin-Paturel, M Colonna, U Kalinke